Modified Citrus Pectin (MCP) interferes with the inflammatory process by binding to galectin-3’s carbohydrate recognition domain – preventing galectin-3 from otherwise binding to ligands, interacting with cells, or forming lattice structures.

By disrupting the cell-to-cell, cell-to-galectin-3, and galectin-3-to-galectin-3 interactions, MCP creates an environment that is inhospitable to inflammation, fibrosis, hypoxia, infection, and cancer cell growth.

In the case of cancer, for example, it removes the galectin-3 that “shields” the cancer, and blocks the galectin-3 that inhibits the immune response. This wakes up the immune cells and enhances the normal immune response, making the immune cells more effective.

This chapter – “A Gift From Nature: Modified Citrus Pectin” – is from Dr. Isaac Eliaz' new book “The Survival Paradox.”